HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryuta Miyake Selected Research

Ovarian Neoplasms (Ovarian Cancer)

1/2022Tissue Factor Pathway Inhibitor 2: A Novel Biomarker for Predicting Asymptomatic Venous Thromboembolism in Patients with Epithelial Ovarian Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryuta Miyake Research Topics

Disease

4Neoplasms (Cancer)
11/2023 - 07/2021
2Ovarian Epithelial Carcinoma
02/2022 - 01/2022
2Venous Thromboembolism
02/2022 - 01/2022
1Neoplasm Metastasis (Metastasis)
11/2023
1Endometrial Neoplasms (Endometrial Cancer)
11/2023
1Lymphatic Metastasis
11/2023
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Residual Neoplasm
01/2022
1Ascites
01/2022
1Carcinoma (Carcinomatosis)
09/2021
1Menstruation Disturbances
11/2017
1Endometriosis
11/2017

Drug/Important Bio-Agent (IBA)

2fibrin fragment D (D-dimer)IBA
02/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2022
2tissue-factor-pathway inhibitor 2 (PP5)IBA
02/2022 - 01/2022
1CA-125 Antigen (CA 125 Antigen)IBA
11/2023
1Thromboplastin (Tissue Factor)IBA
11/2023
1CI 22IBA
05/2022
1plitidepsin (aplidine)IBA
09/2021
1IronIBA
11/2017
1Histones (Histone)IBA
11/2017
1Hemoglobins (Hemoglobin)IBA
11/2017
1Heme (Haem)IBA
11/2017

Therapy/Procedure

2Laparotomy
05/2022 - 07/2021